Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Nano Letters|January 20, 2022
Peptide Assembled in a Nano-confined Space as a Molecular Rectifier for the Availability of Ionic Current ModulationLiu Shi, Deqi Kuang, Xuemei Ma, et al.
Molecular Nutrition & Food Research|September 30, 2024
Association between Higher Intake of Flavonols and Lignans and Better Mood: Evidence from Dietary and Biomarker Evaluation in Healthy IndividualsXuemei Ma, Yifan Xu, Yong Li, et al.
International Journal of Molecular Sciences|November 25, 2018
Jatrorrhizine Hydrochloride Suppresses RANKL-Induced Osteoclastogenesis and Protects against Wear Particle-Induced OsteolysisHui Li, Jing Wang, Qiwen Sun, et al.
Cell Death & Disease|February 17, 2019
MiR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathwayTingting Wang, Gang Chen, Xuemei Ma, et al.
Frontiers in Cell and Developmental Biology|November 29, 2023
Mitochondria: one of the vital hubs for molecular hydrogen's biological functionsXiaoyue Zhang, Fei Xie, Shiwen Ma, et al.
Frontiers in Medicine|July 17, 2023
Missing link between tissue specific expressing pattern of ERβ and the clinical manifestations in LGBLELXujuan Zhang, Pengxiang Zhao, Mingshen Ma, et al.
Angewandte Chemie (International Ed. in English)|October 17, 2023
Green Ether Electrolytes for Sustainable High-voltage Potassium Ion BatteriesXuemei Ma, Hongwei Fu, Jingyi Shen, et al.
Scientific Reports|March 11, 2022
Long-term and daily use of molecular hydrogen induces reprogramming of liver metabolism in rats by modulating NADP/NADPH redox pathwaysYao Mawulikplimi Adzavon, Fei Xie, Yang Yi, et al.
Frontiers in Oncology|July 12, 2021
MDM2 Binding Protein Induces the Resistance of Hepatocellular Carcinoma Cells to Molecular Targeting Agents <i>via</i> Enhancing the Transcription Factor Activity of the Pregnane X ReceptorQiyu Jiang, Yan Ma, Jingjing Han, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 14, 2016
TXR1 and TSP1 expression varies by the molecular subtypes of breast cancer patients who received previous docetaxel-based first-line chemotherapyHuiming Zhang, Xiang Qu, Xuemei Ma, et al.
Pageof 16